About PharmaIN
PharmaIN is a Healthcare company based in Bothell (United States) founded in 2001. Proprietary drug delivery platforms are developed for API enhancement. PharmaIN has raised $1.5 million across 21 funding rounds from investors including HHS. PharmaIN offers products and services including PHIN-214 and Proprietary Peptide Drugs. Its focus areas include Life Sciences, Drug Delivery, Nanoparticle Based and Gastroenterology. Its legal entity is PharmaIN Corporation. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2001 and based in Bothell, United States, PharmaIN operates in the biotechnology sector. Proprietary technology platforms, including Protected Graft Copolymer (PGC) and various core binding moieties, are utilized to enhance active pharmaceutical ingredients and enable drug delivery. Preclinical products in development include PHIN-1138 for congestive heart failure, PHIN-1722 for diabetes and obesity, PHIN-438 for auto-immune disease, and PHIN-103 for ascites and hepato-renal syndrome.
- Headquarters Bothell, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pharmain.com
- Social LinkedIn
- Legal Name Pharmain Corporation
- Total Equity Funding$1.5M (USD)
in 21 rounds
- Latest Funding Round$1.99M (USD), Grant
Jun 2023
- Investors
Products & Services of PharmaIN
PharmaIN offers a comprehensive portfolio of products and services, including PHIN-214 and Proprietary Peptide Drugs.
Therapy for in-home treatment of liver disease and cancer.
Drugs designed for in-home management of chronic diseases like cirrhosis.
Funding Insights of PharmaIN
PharmaIN has successfully raised a total of $1.5M across 21 strategic funding rounds. The most recent funding activity was a Grant round of $1.99 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.5M
- Total Rounds 21
- Last Round Grant — $1.99M
- First Round $2.1M
(Jun 2004)
- Investors Count 1
Latest 10 of 21 funding rounds of PharmaIN with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | $1.99M | Grant | – | – | |
| Jun 2022 | $1.97M | Grant | – | – | |
| Jun 2017 | $2M | Grant | – | – | |
| Jun 2014 | $5.52M | Grant | – | – | |
| May 2014 | $1.5M | Seed | – | – | – |
| Jun 2012 | $371,968 | Grant | – | – | |
| May 2012 | $600,000 | Grant | – | – | |
| Jul 2011 | $599,949 | Grant | – | – | |
| Jun 2011 | $599,949 | Grant | – | – | |
| Jun 2010 | $1.17M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in PharmaIN
PharmaIN has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for PharmaIN
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PharmaIN
4 people are tracked at PharmaIN (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Elijah B. | Founder, President and CEO | Leadership |
Gerry Castillo | Vice President, Intellectual Property & Grants | Distinguished Scientist At Pharmain, Corp. | Leadership |
Molly Dorr | Sr. Director Of Human Resources | Leadership |
Akiko Nishimoto-Ashfield | Alliance Manager | Team |
Complete people profiles for PharmaIN
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PharmaIN
3 dated milestones of PharmaIN across 22 years, from founding to its latest funding, stage changes and deals.
- Founded PharmaIN is founded.
- Funding First funding round of $2.1M.
- Funding Latest funding round, Grant, of $2.0M.
Competitors of PharmaIN
PharmaIN has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of PharmaIN
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PharmaIN
The website of PharmaIN (pharmain.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 14.7% vs previous month
Websites whose visitors overlap most with PharmaIN. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| faradaypharma.com | 100% | View details | |||
| omeros.com | 100% | 15.6K | #1,695,799 | View details | |
| soundpharma.com | 98% | 2.7K | #5,693,412 | View details | |
| talus.bio | 98% | 4.4K | #4,306,649 | View details | |
| alpenglowbiosciences.com | 96% | 3.7K | #4,504,338 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for PharmaIN
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Gastroenterology
3 companies that operate in the same segment as PharmaIN (Gastroenterology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | 411 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmain
Complete news archive for PharmaIN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmaIN
PharmaIN was founded in 2001 and raised its 1st funding round 3 years after it was founded.
PharmaIN is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
PharmaIN is a funded company, having raised a total of $1.5M across 21 funding rounds to date. The company's 1st funding round was a Grant of $1.17M, raised on Jun 2004.
Founded in 2001 and based in Bothell, United States, PharmaIN operates in the biotechnology sector. Proprietary technology platforms, including Protected Graft Copolymer (PGC) and various core binding moieties, are utilized to enhance active pharmaceutical ingredients and enable drug delivery. Preclinical products in development include PHIN-1138 for congestive heart failure, PHIN-1722 for diabetes and obesity, PHIN-438 for auto-immune disease, and PHIN-103 for ascites and hepato-renal syndrome.
PharmaIN's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
PharmaIN offers PHIN-214 and Proprietary Peptide Drugs.
PharmaIN has 1 investor. Key investors include HHS.
PharmaIN operates through Pharmain Corporation.